Tuesday, 14 August 2012

Production Of Cyclic Peptides


Cyclic peptides are considerably more stable than linear peptides due to their resistance to proteases.  They can also cross cell membranes effectively.  Consequently, they are of great interest to the biotechnology and pharmaceutical industries.  Although peptide macrocycles are found in many natural products, current synthetic methods are inefficient, resulting in low yields, and are not economically viable.
Researchers at the Universities of Aberdeen and St Andrews have developed an efficient process for the production of diverse cyclic peptides that allows complete conversion thus removing the requirement for separation and recycling of starting materials.
A key aspect of this method is the use of engineered versions of the macrocyclase patG, an enzyme from the patellamide biosynthetic pathway.  Engineering of the patG protein has allowed a process to be developed that enables the synthesis of cyclic peptides in greater quantities with higher conversions and at a faster rate than reported previously.  This process will also allow the synthesis of a diverse range of cyclic peptides with a number of possible post-translational or post-synthetic modifications.
Key Benefits:
  • Process for production of cyclic peptides
  • Potential for production of diverse range of cyclic peptides
  • Production of peptides containing non-natural amino acids
  • 100% conversion of linear to cyclic peptides possible
  • Improvement in rate of synthesis and quantities produced
  • Potential for multiple modifications of peptide amino acid residues
Applications:
  • Production of cyclic peptides for applications in the biotechnology and pharmaceutical industries

No comments:

Post a Comment

Note: only a member of this blog may post a comment.